Natural History Study for Patients With Nemaline Myopathy in Spain
Recruiting now
Conditions studied: Nemaline Myopathy, Myopathies, Myopathic Conditions, NEB, ACTA1, TPM2, TPM3, TNNT1, CFL2, KBTBD13, KLHL40, KLHL41, LMOD3, Cohort Studies, MYPN, TNNT3
In brief
The objective of this natural history study is to comprehensively characterize the disease progression and clinical features of nemaline myopathies. The study aims to establish a well-defined cohort of patients in Spain, enabling long-term follow-up and facilitating recruitment for future clinical trials.
Key facts
- Study ID
- NCT07488806
- Run by
- Hospital Universitari Vall d'Hebron Research Institute
- People needed
- 100
- Starts
- 2026-06-01
- Expected to finish
- 2032-06-01
- Last updated by the study team
- 2026-03-23
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with a confirmed clinical and genetic diagnosis of MN (mutations in ACTA1, NEB, TPM2, TPM3, KBTBD13, CFL2, KLHL40, KLHL41, LMOD3, MYPN, TNNT1, TNNT3), or under discussion if they only have a compatible biopsy.
- Signed informed consent by the patient or Legal Authority Responsible, and/or assent by the subject (in pediatric population).
Where it is running
- University Hospital Vall d'Hebron — Barcelona, Spain (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.